Bioisosteric Replacement
Bioisosteric Replacement is a medicinal chemistry strategy in which an atom, ion, or group of atoms in a lead compound is systematically substituted with a bioisostere that preserves the essential steric and electronic characteristics of the original moiety while modulating physicochemical, pharmacokinetic, and safety properties so as to maintain or improve the compound’s biological activity.
135
Publications
6.5K
Citations
831
Authors
210
Institutions
Publications per year
2017–2026
42
Variants
Bioisosteric Replacements
135
Oxadiazoles in Medicinal Chemistry
Jonas Boström, Anders Hogner, Antonio Llinàs et al. · Journal of Medicinal Chemistry · 2011 · 595 citations · Full text
Structure Property Relationships of Carboxylic Acid Isosteres
Pierrik Lassalas, Bryant Gay, Caroline Lasfargeas et al. · Journal of Medicinal Chemistry · 2016 · 284 citations · Full text
1–5 of 135
831
4
h-index
3
h-index
A.E. Arbuzov Institute of Organic and Physical Chemistry, Russia
2 publications · 35 citations
2
h-index
2
h-index
2
h-index
1–5 of 831
210
Novartis (Switzerland)
Basel, Switzerland
4 h-index
6 publications
391 citations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Rahway, United States
4 h-index
27 publications
989 citations

Institute of Cancer Research
London, United Kingdom
4 h-index
13 publications
768 citations
Novartis Institutes for BioMedical Research
Basel, Switzerland
4 h-index
6 publications
391 citations

University of Groningen
Groningen, The Netherlands
3 h-index
7 publications
184 citations

Novo Nordisk (Denmark)
Copenhagen, Denmark
3 h-index
7 publications
190 citations

Chinese Academy of Sciences
Beijing, China
3 h-index
24 publications
452 citations

Lomonosov Moscow State University
Moscow, Russia
3 h-index
3 publications
78 citations
1–8 of 210
24 publications · 2K citations
18
h-index
20 publications · 441 citations
15
h-index
10 publications · 429 citations
10
h-index
9 publications · 308 citations
9
h-index
6 publications · 470 citations
6
h-index
1–5